ArticleOncotarget2015

Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.

Paola Orecchia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.